Copeptin and its clinical implications in the setting of vasovagal syncope

Yalta, Kenan2024-06-122024-06-1220170167-52731874-1754https://doi.org/10.1016/j.ijcard.2017.03.008https://hdl.handle.net/20.500.14551/24778[Abstract Not Available]en10.1016/j.ijcard.2017.03.008info:eu-repo/semantics/closedAccessArginine-Vasopressin IncreasesCopeptin and its clinical implications in the setting of vasovagal syncopeLetter2422828Q2WOS:0004054555000262-s2.0-8502039928028619331Q1